Explore Vaccination Progress by U.S. State
With dozens of COVID-19 vaccines now in clinical trials, it is important to understand the accelerated timelines for development, the different types of vaccines available, and the facts related to vaccine safety and efficacy. Additionally, as vaccines are approved, we will track data on vaccination efforts.
An interactive tool from our vaccine experts that explores how a vaccine is developed and the differences between a typical timeline and an accelerated timeline.
VIEW-hub is a publicly available interactive tool that displays up-to-date information on vaccine characteristics, and vaccine introduction and use globally. Vaccines include COVID-19 as well as many childhood vaccines in routine immunization programs.
Many European nations – including France, Germany, Italy, Portugal, and Spain – recently paused the use of AstraZeneca’s vaccine due to alleged adverse reactions.
A history of formal medical exploitation and decades of institutional and cultural racism have entrenched that mistrust and fear, according to research co-authored by Rupali Limaye.
This series of brief reports will shed light on COVID-19 vaccine development, allocation and deployment in the United States and globally. Topics will include ensuring the safety and efficacy of Covid-19 vaccines, principles for vaccine allocation, strategies for deployment and delivery of Covid-19 vaccines, vaccine confidence and demand, and the economics of Covid-19 vaccines.
COVID-19 VACCINE MATTERS: A blog series discussing the evolving science and policy of COVID-19 vaccines, led by internationally renowned experts in vaccine development, Dr. Larry Corey of the Univeristy of Washington, and Dr. Chris Beyrer of Johns Hopkins University.
Johns Hopkins University and the University of Washington hosted a high-level symposium, “The Scientific Integrity of COVID-19 Vaccine Efficacy Trials: From Clinical Trials to Public Allocation,” that explored complex issues, brought together leading voices in the field, and put forward a concise plan for protecting the scientific integrity of these ongoing efforts.
Chris Hayes is joined by Jennifer Nuzzo to discuss the distribution of vaccines around the world and spreading coronavirus variants.
Joe Biden’s declaration that all adults should be eligible for coronavirus vaccinations by May 1 will require a shift for states that have been methodical in how they roll out the shots.
The United States now has three vaccines available to combat COVID-19. Here's everything you need to know about the extent and nature of the vaccines’ side effects, and how to deal with them.
On March 8, the U.S. Centers for Disease Control and Prevention released their interim recommendations for people who have been fully vaccinated.
Doctors and public health experts emphasize that people should take the first vaccine offered to them.
Health care workers were among the first to be vaccinated in this country, but that experience of getting vaccinated is not the same for some foreign-born doctors.
In this podcast episode, pediatrician and vaccine expert Dr. William Moss discusses the different COVID-19 vaccines and how neglect of other vaccines could lead to the next big public health crisis.
COVAX, an international initiative tasked with ensuring more equitable access to COVID-19 vaccines, aims to redress this imbalance between nations by securing deals that send shots to low-income countries free of charge.
The anticipated authorization of a third coronavirus vaccine has raised a new question for many Americans: Which shot should I get?
A new study involving more than half a million people who were vaccinated in Israel strongly suggests the vaccines have remained effective in preventing symptoms of COVID-19.